ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $819,000 | -17.5% | 29,200 | 0.0% | 0.24% | -23.5% |
| Q3 2021 | $993,000 | -16.8% | 29,200 | 0.0% | 0.31% | -18.8% |
| Q2 2021 | $1,193,000 | +1.4% | 29,200 | 0.0% | 0.38% | -5.4% |
| Q1 2021 | $1,176,000 | -31.9% | 29,200 | 0.0% | 0.40% | -34.9% |
| Q4 2020 | $1,727,000 | -3.5% | 29,200 | -20.7% | 0.62% | -15.4% |
| Q3 2020 | $1,790,000 | -15.9% | 36,800 | -16.4% | 0.74% | -26.4% |
| Q2 2020 | $2,129,000 | +42.4% | 44,000 | -18.2% | 1.00% | +23.4% |
| Q1 2020 | $1,495,000 | – | 53,800 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |